FDA’s Expedited PMA Pathway Proposal: To Expand Or Contain?

Companies want FDA to expand the bounds of its accelerated device development program, while others urge FDA to be cautious.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation